EE04677B1 - Tetrahdropridoeetrid, nende kasutamine ja ravim - Google Patents

Tetrahdropridoeetrid, nende kasutamine ja ravim

Info

Publication number
EE04677B1
EE04677B1 EEP200100172A EEP200100172A EE04677B1 EE 04677 B1 EE04677 B1 EE 04677B1 EE P200100172 A EEP200100172 A EE P200100172A EE P200100172 A EEP200100172 A EE P200100172A EE 04677 B1 EE04677 B1 EE 04677B1
Authority
EE
Estonia
Prior art keywords
ridoethers
tetrah
medicine
drop
naphthyridine
Prior art date
Application number
EEP200100172A
Other languages
English (en)
Estonian (et)
Inventor
Senn-Bilfinger J�rg
Postius Stefan
Simon Wolfgang-Alexander
Grundler Gerhard
Hanauer Guido
Huber Reinhard
Kromer Wolfgang
Sturm Ernst
Original Assignee
Byk Gulden Lomberg Chemische Fabrik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik Gmbh filed Critical Byk Gulden Lomberg Chemische Fabrik Gmbh
Publication of EE200100172A publication Critical patent/EE200100172A/xx
Publication of EE04677B1 publication Critical patent/EE04677B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
EEP200100172A 1998-09-23 1999-09-17 Tetrahdropridoeetrid, nende kasutamine ja ravim EE04677B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98117988 1998-09-23
DE19843504 1998-09-23
PCT/EP1999/006899 WO2000017200A1 (en) 1998-09-23 1999-09-17 Tetrahydropyridoethers

Publications (2)

Publication Number Publication Date
EE200100172A EE200100172A (et) 2002-06-17
EE04677B1 true EE04677B1 (et) 2006-08-15

Family

ID=26049024

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100172A EE04677B1 (et) 1998-09-23 1999-09-17 Tetrahdropridoeetrid, nende kasutamine ja ravim

Country Status (31)

Country Link
US (4) US6436953B1 (xx)
EP (1) EP1115725B1 (xx)
JP (1) JP4145492B2 (xx)
KR (1) KR100668400B1 (xx)
CN (2) CN100506821C (xx)
AT (1) ATE231862T1 (xx)
AU (1) AU763463B2 (xx)
BG (1) BG65195B1 (xx)
BR (1) BR9914044A (xx)
CA (1) CA2344251A1 (xx)
CZ (1) CZ292335B6 (xx)
DE (1) DE69905178T2 (xx)
DK (1) DK1115725T3 (xx)
EA (1) EA005377B1 (xx)
EE (1) EE04677B1 (xx)
ES (1) ES2191464T3 (xx)
GE (1) GEP20032926B (xx)
HK (1) HK1038360B (xx)
HR (1) HRP20010224A2 (xx)
HU (1) HUP0102990A3 (xx)
ID (1) ID28896A (xx)
IL (2) IL142063A0 (xx)
NO (1) NO317304B1 (xx)
NZ (1) NZ510610A (xx)
PL (1) PL193616B1 (xx)
PT (1) PT1115725E (xx)
RS (1) RS50145B (xx)
SI (1) SI1115725T1 (xx)
SK (1) SK285165B6 (xx)
TR (1) TR200100805T2 (xx)
WO (1) WO2000017200A1 (xx)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL193616B1 (pl) 1998-09-23 2007-02-28 Altana Pharma Ag Tetrahydropirydoetery
CA2370231A1 (en) * 1999-04-17 2000-10-26 Byk Gulden Lomberg Chemische Fabrik Gmbh Haloalkoxy imidazonaphthyridines
CA2285516C (en) * 1999-05-12 2010-12-07 President And Fellows Of Harvard College Dopamine transporter imaging agents
EA005597B1 (ru) * 2000-03-29 2005-04-28 Алтана Фарма Аг Пролекарства производных имидазопиридина
PL365165A1 (en) * 2000-03-29 2004-12-27 Altana Pharma Ag Tricyclic imidazopyridines
JP2004512338A (ja) 2000-10-25 2004-04-22 アルタナ　ファルマ　アクチエンゲゼルシャフト 胃液分泌抑制剤としてのポリ置換イミダゾピリジン
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
EE05234B1 (et) * 2001-03-08 2009-12-15 Astrazeneca Ab 6-karboksamidoimidaso[1,2-a] pridiinihendite kasutamine ravimi p?hjustatud maohaavandi v„ltimiseks
JP2005500372A (ja) 2001-08-02 2005-01-06 アルタナ　ファルマ　アクチエンゲゼルシャフト 三環エポキシド
EP1417208A1 (en) * 2001-08-03 2004-05-12 ALTANA Pharma AG Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases
JP2005504048A (ja) * 2001-08-03 2005-02-10 アルタナ　ファルマ　アクチエンゲゼルシャフト 胃腸障害治療用のアルカリ置換されたイミダゾピリジン
CN1633435A (zh) 2002-02-15 2005-06-29 奥坦纳医药公司 三环n－酰基化合物
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
WO2003094967A2 (en) * 2002-05-07 2003-11-20 Altana Pharma Ag New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders
CA2506027A1 (en) 2002-11-19 2004-06-03 Altana Pharma Ag 8-substituted imidazopyridines
DE60323138D1 (de) 2002-12-12 2008-10-02 Nycomed Gmbh Kombinationsarzneimittel aus r,r-formoterol und ciclesonide
RS20050449A (xx) * 2002-12-20 2007-11-15 Altana Pharma Ag., 8-trialkisiloksi-2-metil-9-fenil-7- okso-7,8,9,10- tetrahidroimidazo /1,2h//1,7/naftiridini
EP1599175A2 (en) * 2003-02-17 2005-11-30 ALTANA Pharma AG Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders
EA009985B1 (ru) 2003-03-10 2008-04-28 Никомед Гмбх Новый способ получения рофлумиласта
TW200503783A (en) * 2003-04-11 2005-02-01 Altana Pharma Ag Oral pharmaceutical preparation for proton pump antagonists
SA04250092B1 (ar) * 2003-05-14 2008-05-04 التانا فاروا ايه جي مركب وسيط جديد لتحضير مركبات إيميدازوبيريدين imidazopyridines فعالة علاجياً
JP2006528231A (ja) * 2003-05-27 2006-12-14 アルタナ　ファルマ　アクチエンゲゼルシャフト プロトンポンプ阻害剤と胃腸運動性を変更する化合物との医薬品組合せ物
AU2004268641A1 (en) * 2003-08-29 2005-03-10 Dynogen Pharmaceuticals, Inc. Compositions useful for treating gastrointestinal motility disorders
ES2452691T5 (es) 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
AU2004285394B2 (en) * 2003-11-03 2009-01-08 Astrazeneca Ab Imidazo (1,2-A) pyridine derivatives for the treatment of silent gastro-esophageal reflux
US7326784B2 (en) 2003-12-19 2008-02-05 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano-imidazo-pyridines derivatives
NZ549011A (en) * 2004-02-17 2009-04-30 Altana Pharma Ag Tricyclic imidazopyridines and intermediates for the synthesis thereof
DK1784402T3 (da) 2004-09-03 2011-11-14 Yuhan Corp Pyrrolo[3,2-c]pyridinderivater samt fremgangsmåder til deres fremstilling
US7662832B2 (en) 2004-09-03 2010-02-16 Yuhan Corporation Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof
CA2579127C (en) 2004-09-03 2011-08-02 Yuhan Corporation Pyrrolo[3,2-b]pyridine derivatives and processes for the preparation thereof
CA2601250C (en) * 2005-03-16 2014-10-28 Nycomed Gmbh Taste masked dosage form containing roflumilast
EP2080513A1 (en) 2008-01-16 2009-07-22 Schraermeyer, Ulrich, Prof. Dr. rer. nat Tetrahydropyridoethers for treatment of AMD
WO2011004882A1 (ja) 2009-07-09 2011-01-13 ラクオリア創薬株式会社 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤
WO2012027240A1 (en) * 2010-08-23 2012-03-01 Schering Corporation Fused tricyclic inhibitors of mammalian target of rapamycin
BR112014031396B1 (pt) * 2012-06-15 2019-11-26 Bio Pharm Solutions Co Ltd composto de sulfamato de fenilalquila e composição de relaxante muscular compreendendo o mesmo
EP3054949A1 (en) 2013-10-08 2016-08-17 Katairo GmbH Tetrahydropyridoethers for the treatment of stargardt's disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
JP2656101B2 (ja) 1987-07-16 1997-09-24 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング 新規ジアゾール
SE9401197D0 (sv) * 1994-04-11 1994-04-11 Astra Ab Active compounds
JPH10505332A (ja) * 1994-07-28 1998-05-26 ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング アシルイミダゾピリジン
EA002402B1 (ru) * 1997-03-24 2002-04-25 Бык Гульден Ломберг Хемише Фабрик Гмбх Тетрагидропиридо-соединения
HUP0001555A3 (en) * 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
PL193616B1 (pl) * 1998-09-23 2007-02-28 Altana Pharma Ag Tetrahydropirydoetery

Also Published As

Publication number Publication date
HUP0102990A2 (hu) 2002-01-28
CA2344251A1 (en) 2000-03-30
DE69905178D1 (de) 2003-03-06
ID28896A (id) 2001-07-12
KR100668400B1 (ko) 2007-01-17
NZ510610A (en) 2003-07-25
CN1560055A (zh) 2005-01-05
RS50145B (sr) 2009-03-25
EE200100172A (et) 2002-06-17
CN1155598C (zh) 2004-06-30
ES2191464T3 (es) 2003-09-01
BG105270A (en) 2001-11-30
EA005377B1 (ru) 2005-02-24
BG65195B1 (bg) 2007-06-29
KR20010075223A (ko) 2001-08-09
HUP0102990A3 (en) 2002-09-30
SK285165B6 (sk) 2006-07-07
NO20011243L (no) 2001-03-12
NO317304B1 (no) 2004-10-04
US6436953B1 (en) 2002-08-20
CZ292335B6 (cs) 2003-09-17
ATE231862T1 (de) 2003-02-15
US20040162310A1 (en) 2004-08-19
JP2002526499A (ja) 2002-08-20
GEP20032926B (en) 2003-03-25
WO2000017200A1 (en) 2000-03-30
BR9914044A (pt) 2001-12-04
US6696460B2 (en) 2004-02-24
DE69905178T2 (de) 2003-07-17
AU763463B2 (en) 2003-07-24
PT1115725E (pt) 2003-06-30
EA200100315A1 (ru) 2001-10-22
AU6192099A (en) 2000-04-10
JP4145492B2 (ja) 2008-09-03
DK1115725T3 (da) 2003-06-23
SI1115725T1 (en) 2003-06-30
NO20011243D0 (no) 2001-03-12
HK1038360B (zh) 2003-05-16
US7393860B1 (en) 2008-07-01
EP1115725B1 (en) 2003-01-29
IL142063A (en) 2007-10-31
CN100506821C (zh) 2009-07-01
IL142063A0 (en) 2002-03-10
HRP20010224A2 (en) 2002-04-30
PL346617A1 (en) 2002-02-25
US20020169320A1 (en) 2002-11-14
HK1038360A1 (en) 2002-03-15
CZ20011082A3 (cs) 2001-09-12
EP1115725A1 (en) 2001-07-18
YU21401A (sh) 2004-03-12
CN1319101A (zh) 2001-10-24
US7105676B2 (en) 2006-09-12
PL193616B1 (pl) 2007-02-28
SK3992001A3 (en) 2001-12-03
TR200100805T2 (tr) 2001-08-21

Similar Documents

Publication Publication Date Title
EE04677B1 (et) Tetrahdropridoeetrid, nende kasutamine ja ravim
EE04676B1 (et) Imidasopridiini derivaadid, mis inhibeerivad maohappesekretsiooni, protsess nende valmistamiseks ning nende kasutamine
EE04800B1 (et) Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks
FI974440A0 (fi) Bifenyyli-2-karboksyylihappo-tetrahydro-isokinolin-6-yyli-amidijohdannaisia, niiden valmistus ja niiden käyttö mikrosomaalistatriglyseridiä siirtävän proteiinin ja/tai apolipoproteiini B:n (Apo B) erittymiseen inhibiittoreina
NO961006L (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
DE10299001I1 (de) Erythromycinderivate, ihre Verfahren zur Herstellung und ihre Verwendung als Arzneimittel.
DK0914119T3 (da) Fremgangsmåde til fremstilling af faste orale dosisformer af valsartan
EE9900441A (et) Farmatseutiline kompositsioon N-piperidino-3-pürasoolkarboksamiidi derivaadi, tema soolade ja nende solvaatide suu kaudu manustamiseks
EE04060B1 (et) Heterotsüklilised ühendid maohappesekretsiooni inhibeerimiseks, protsess nende valmistamiseks ja ravimkoostised
NO882472D0 (no) Fremgangsmaate for fremstilling av peptidborsyreinhibitorer for trypsinlignende proteaser.
EE03568B1 (et) Bensimidasooli derivaadid, nende valmistamismeetod ja kasutamine
NO911934L (no) Fremgangsmaate for fremstilling av bicykliske 1-aza-cykloalkaner.
FI990134A (fi) Pyridatsino-(4,5-beta)-kinoliini-5-oksidijohdannaisia, niiden valmistus ja niiden käyttö glysiiniantagonisteina
EE03682B1 (et) Asendatud bensimidasooli derivaadid, protsessid nende valmistamiseks ning nende kasutamine
DE69909577D1 (de) Derivate von Erythromycin, ihr Verfahren zur Herstellung, und ihre Verwendung als Arzneimittel
ATE218567T1 (de) 1h-pyrido(3,4-b)indolcarboxamidderivate, ihre herstellung und therapeutische verwendung
IS4367A (is) CCK eða gastrín temprandi 5-heterósýklísk-1,5-bensódíazepín
AU7788500A (en) Use of substance p antagonists for influencing the circadian timing system
IS2199B (is) Svæfandi ß-karbólín afleiður, aðferð til framleiðslu þeirra og notkun þeirra sem læknislyf
NO20003454D0 (no) FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
NO20012541D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
EE200000537A (et) Pürasolo[4,3-d]pürimidiin-7-oon-3-püridüülsulfonüülühendite ja nende vaheühendite valmistamise protsess
DE59708511D1 (de) Verwendung von 7-(1-aminomethyl-2-oxa-7-aza-bicyclo 3.3.0]oct-7-yl)-chinoloncarbonsäure- und -naphthyridoncarbonsäure-derivaten zur therapie von helicobacter-pylori-infektionen und den damit assoziierten gastroduodenalen erkrankungen
DE69719190D1 (de) Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20100917